首页 | 本学科首页   官方微博 | 高级检索  
     

醋酸艾塞那肽在Wistar大鼠体内的药物代谢动力学研究
引用本文:艾国,陈知航,单成启,车津晶,侯禹男,程远国. 醋酸艾塞那肽在Wistar大鼠体内的药物代谢动力学研究[J]. 中国药学, 2008, 17(1): 6-10
作者姓名:艾国  陈知航  单成启  车津晶  侯禹男  程远国
作者单位:艾国(军事医学科学院,微生物流行病研究所,药物代谢动力学实验室,北京,100071);陈知航(军事医学科学院,微生物流行病研究所,药物代谢动力学实验室,北京,100071);单成启(军事医学科学院,微生物流行病研究所,药物代谢动力学实验室,北京,100071);车津晶(军事医学科学院,微生物流行病研究所,药物代谢动力学实验室,北京,100071);侯禹男(军事医学科学院,微生物流行病研究所,药物代谢动力学实验室,北京,100071);程远国(军事医学科学院,微生物流行病研究所,药物代谢动力学实验室,北京,100071)
基金项目:国家高技术研究发展计划(863计划)
摘    要:研究醋酸艾塞那肽(exendin-4)在Wistar大鼠体内的药物代谢动力学,组织分布以及排泄特征。IODOGEN(四氯二苯基苷脲)法制备^125I-exendin-4,大鼠皮下或静脉注射,^125I-exendin-4,以放射性核素示踪动力法检测血液中的药物浓度,由非房室模型评价药物动力学参数。同时研究了大鼠皮下注射^125I-exendin-4后的组织分布和排泄。大鼠皮下注射^125I-exendin-4后Tmax和t1/2分别是(0.25±0.02)h和(1.28±0.14)h,绝对生物利用度为(65.5±10.2)%;^125I-exendin-4的分布快速而广泛,其中以肾脏中最高,而在脑组织中只有微量^125I-exendin-4;^125I-exendin-4主要随尿液排泄。实验结果与国外公布的实验数据基本一致。醋酸艾塞那肽在大鼠中的药物代谢动力学参数为临床试验提供了科学依据。

关 键 词:醋酸艾塞那肽  碘标记  药物代谢动力学
文章编号:1003-1057(2008)1-06-05
修稿时间:2007-06-18

Pharmacokinetics of exendin-4 in Wistar rots
Guo Ai,Zhi-Hang Chen,Cheng-Qi Shan,Jin-Jing Che,Yu-Nan Hou,Yuan-Guo Cheng. Pharmacokinetics of exendin-4 in Wistar rots[J]. Journal of Chinese Pharmaceutical Sciences, 2008, 17(1): 6-10
Authors:Guo Ai  Zhi-Hang Chen  Cheng-Qi Shan  Jin-Jing Che  Yu-Nan Hou  Yuan-Guo Cheng
Affiliation:(Laboratory of Drug Metabolism and Pharmacokinetics, Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China)
Abstract:To characterize the preclinical pharmacokinetics, tissue distribution and excretion profiles of exendin-4 in healthy Wistar rats were studied. Exendin-4 was radioiodinated by the IODOGEN (1,3,4,6-tetrachloro-3 alpha, 6 alphadiphenylglucoluril) method. Pharrnacokinetic properties of ^125I-exendin-4 were examined after a single s.c. and i.v. injection, respectively. Tissue distri- bution and urinary, fecal, and biliary excretion patterns of ^125I-exendin-4 were also investigated following a single s.c. injection. Exendin-4 was rapidly distributed and cleared with t1/2 of (0.48 ± 0.03) h after a single i.v. injection. Following a single s.c. administration, exendin-4 exhibited rapid and considerable absorption with Tmax of (0.25± 0.02) h and declined with the elimination t1/2 of(1.28± 0.14) h. The absolute bioavailability was (65.5 ± 10.2) %. The radioactivity was widely distributed and rapidly diminished in most tissues. The kidney contained the highest radioactivity and the distribution of ^125I-exendin-4 to the brain was minimal. The major elimination route was urinary excretion. The pharmacokinetic properties of exendin-4 obtained from the present study closely matched those reported in previous studies in rats. Pharmacokinetics profiles of exendin-4 in rats are warranted for the design of future clinical trials.
Keywords:Exendin-4  Iodine  Pharmacokinetics
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《中国药学》浏览原始摘要信息
点击此处可从《中国药学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号